Kualitas Hidup Pasien Hipertensi Rawat Jalan di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta Dengan Terapi Kombinasi Angiotensin Reseptor Blocker dan Calcium Channel Blocker

  • Andriana Sari
  • Faridah Baroroh

Abstract

Hypertension medication may utilize a single antihypertensive or combined antihypertensives in accordance with the patient’s condition. Hypertension medication is carried out in a lengthy period and thus can affect the patient’s quality of life. This study aims to assess the quality of life of hypertensive outpatients under combination therapy with an angiotensin receptor blocker and a calcium channel blocker at a private hospital in Yogyakarta. The research applied a prospective cohort design, where the outcome observations were made three months after medication, on patients meeting the inclusion criteria by gauging their quality of life through validated EQ5D questionnaires and a VAS method. Analysis of the quality of life used the conversion of EQ5D dimension scores into an EQ5D index score and the VAS data by calculating the mean and standard deviation. Analysis of differences in quality of life between 3 antihypertensive drug combinations employed an ANOVA test. Results show that of 58 patients, 24 received a candesartan-amlodipine combination, 9 had candesartan-diltiazem and 25 were given irbesartan-amlodipine; 74.13% were female, 34.48%  were aged 51-60, and the most frequent complication was diabetes mellitus (60.34%). The quality-of-life analysis yielded an EQ5D index score of 1 in 24.14%patients and 0.796 in 13.79 % patients. The mean value from the VAS method is 66.17 with a minimum of 45 and maximum 90. The ANOVA test on the EQ5D quality-of-life index scores of the 3 drug combinations produced a sig value of p = 0.168 while the VAS method’s sig value is p = 0.433. Therefore, there was no significant difference in the quality of life of hypertensive outpatients who received candesartan-amlodipine, candesartan-diltiazem and irbesartan-amlodipine combinations.

References

Annisa. (2013). Penilaian Kualitas Hidup pada Usia Lanjut Dengan Eq-5d Di Klub Jantung Sehat Kelurahan Pondok Kelapa Dan Faktor-Faktor Yang Mempengaruhi, Tesis, Fakultas Kedokteran Universitas Indonesia, Jakarta. http://perpustakaan.fk.ui.ac.id/opac/index.php?p=show_detail&id=16274&keywords=

Anonim,2013, Laporan Riskesdas Nasional tahun 2013, Departemen Kesehatan RI, Jakarta

Da Silva, PM., Haag, U., Guest, JF., Brazier, JE., and Soro , M. (2015). Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension, Health and Quality of Life Outcomes , 2015, 13, 24.

Dahlan, M.S.(2014).Statistik Untuk Kedokteran dan Kesehatan.Jakarta: Epidemiologi Indonesia

Doi, M., Miyoshi T, Hirohata, S., Kamikawa,S., Ogawa H, Ninomiya, Y., Kusachi, S., Usui,S., Youko Kaji, , Sakane, K.,. (2010) Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients, The American Journal of Medical sciences, May 2010, 339 (5), 433-439.

Horowitz, Einav, MD., Abadi-Korek, Ifat,PhD, Shani, Mordechai, MD., Shemer, Joshua, MD. (2010) EQ-5D as a Generic Measure of Health-Related Qualityof Life in Israel: Reliability, Validity and Responsiveness. Israel Medical Assosiation Journal (IMAJ), 12

Kaliyaperumal, S., Hari, SB., , Siddela, PK., , Yadala, S., Assessment of Quality of Life in Hypertensive Patients Journal of Applied Pharmaceutical Science, May 2016, 6 (05), 143-147.

Kustanti, Norma. (2012). Kualitas Hidup Lansia dengan Hipertensi Di Wilayah Kerja Puskesmas KarangmalangKabupaten Sragen, Skripsi, Ilmu Kesehatan Universitas Muhammdiyah Surakarta, Surakarta

Lestari, NY., (2015). Validasi European Quality Of Life 5-Dimensions(EQ-5D) Questionnaire Versi Indonesia Pada Pasien Hipertensi Di Puskesmas Kotagede II Yogyakarta, Skripsi, Farmasi Universitas Ahmad Dahlan, Yogyakarta

Martati, Siringoringo., Hiswani., Jemadi. (2013). Faktor-Faktor Yang Berhubungan Dengan Hipertensi Pada Lansia Di Desa Sigaol Simbolon Kabupaten Samosir Tahun 2013, Jurnal Gizi, Kesehatan Reproduksi dan Epidemiologi,2 (6), diakses dari https://jurnal.usu.ac.id

Novian, Arista. (2013). Faktor Yang Berhubungan Dengan Kepatuhan Diit Pasien Hipertensi, Skripsi,UNNES, Semarang, diakses dari http://lib.unnes.ac.id/18269/1/6450406579.pdf

Oza, BB., Patel, BM., , Malhotra SD.,, Patel, VJ., .(2014). Health Related Quality of Life in Hypertensive Patients in a Tertiary Care Teaching Hospital, Journal of the association of physicians of india, october 2014, 62.

Rustiani, E., Andradjati, R., Arsyanti, L.,. (2014). Analisis Penggunaan Obat Antihipertensi di Poliklinik Rawat Jalan Rumah Sakit PMI Bogor: Perbandingan Cost Effectiveness dan Kualitas Hidup Pasien, Jurnal Ilmu Kefarmasian Indonesia, 12 (2), 210.

Shanableh., S, Abdulkarem., A, Shamssain,M.,, Sarhan F.,.(2014). Quality Of Life of Hypertensive Patients on Different Types of Antihypertensive Medications , IOSR Journal Of Pharmacy, May 2014, 4 (5), 23-28, www.iosrphr.org.

Sumarni, Sri., Amiruddin, Ridwan., Leida, Ida M. Thaha. (2015). Faktor Yang Berhubungan Dengan Kualitas Hidup Penderita Hipertensi Di Wilayah Kerja Puskesmas Segeri,Jurnal Unhas, Bagian Epidemiologi Fakultas Kesehatan Masyarakat Universitas Hasanuddin, Sulawesi.

Tedjasukmana, Pradana. (2012). Tata Laksana Hipertensi, Departemen Kardiologi, RS Premier Jatinegara dan RS Grha Kedoya, Jakarta, Indonesia. CDK-192/ 39 (4). Diakses dari www.kalbemed.com.
Published
2017-12-27
How to Cite
SARI, Andriana; BAROROH, Faridah. Kualitas Hidup Pasien Hipertensi Rawat Jalan di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta Dengan Terapi Kombinasi Angiotensin Reseptor Blocker dan Calcium Channel Blocker. Jurnal Sains dan Teknologi Farmasi, [S.l.], v. 19, n. Supl1, p. s6-s10, dec. 2017. ISSN 2580-5959. Available at: <http://jstf.ffarmasi.unand.ac.id/index.php/jstf/article/view/89>. Date accessed: 26 may 2018.